Flashback: FDA Drug Approvals 2013
Diabetes Compound Alogliptin Approved in Three Formulations
Genzyme’s Kynamro Approved to Treat Inherited Cholesterol Disorder
Celegene’s Pomalyst Approved for Advanced Multiple Myeloma
Kadcyla Approved Under FDA Priority Review Program
Osphena Approved to Treat Painful Sex in Women
FDA Approves Lymphoseek to Map Lymph Nodes in Cancer
Lymphoseek was the first new agent for lymph node mapping to be approved in more than 30 years. Other FDA-approved drugs used for lymph node mapping include sulfur colloid (1974) and isosulfan blue (1981).